Incorporating patient insights into clinical trial design has ‘consistently’ shown to improve timelines.
Outsourcing-Pharma (September 2019)
PM360 asked those with expertise in crafting better experiences for patients key questions about how companies must change to better serve patients.
PM360 (September 2019)
North Carolina CRO has landed a contract with a global biopharmaceutical company with a quickly expanding research portfolio – adding to the firm's prestige in oncology and immunology development.
Triangle Business Journal (August 2019)
Biotech Harbour BioMed has teamed up with CRO PPD to work on creating new oncology and immunology meds.
FierceBiotech (August 2019)
Harbour BioMed (HBM) has selected PPD as its preferred global contract research partner to conduct clinical studies on its internal research pipelines.
WilmingtonBiz (August 2019)
Evidera has entered into an exclusive collaboration agreement with Clinical Study Support, Inc., extending both organizations’ capabilities to deliver more robust consulting and analytical capabilities.
Outsourcing-Pharma (August 2019)
Harbour BioMed (HBM) and PPD have announced a strategic collaboration to develop HBM’s innovative therapeutics in the fields of oncology and immunology.
Krystyna Kowalczyk explains that the collaboration creates meaningful opportunities for cancer patients to participate in clinical trials and access innovative therapies close to home.
FierceBiotech (July 2019)
New collaboration expands opportunities for cancer patients to be treated in the community setting.
Outsourcing-Pharma (July 2019)
Dawie Wessels discusses the five-year study to explore ways to prevent and treat dementia.
WRAL TechWire (July 2019)
We want to hear from you
Register in PPD's Database
© 2019 Pharmaceutical Product Development, LLC. All rights reserved.